Chase

SK Closes Sale of NuCera Solutions to Chase

An affiliate of funds advised by SK Capital Partners has completed the sale of NuCera Solutions to international specialty chemicals company Chase Corp. for $250 million. The companies entered into the agreement on Jul. 18.

News

Allergan Buys US Chase Pharmaceuticals

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Chase

SK Closes Sale of NuCera Solutions to Chase

Allergan Buys US Chase Pharmaceuticals

Top-Feature

API Manufacturing

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

Leading Transformation

Anchored in Sustainability